These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32929455)

  • 1. Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    Roux J; Nekkab N; Colomb-Cotinat M; Astagneau P; Crépey P
    J Antimicrob Chemother; 2021 Jan; 76(1):226-232. PubMed ID: 32929455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015.
    Nekkab N; Crépey P; Astagneau P; Opatowski L; Temime L
    Sci Rep; 2020 Sep; 10(1):14910. PubMed ID: 32913244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.
    Lim YJ; Park HY; Lee JY; Kwak SH; Kim MN; Sung H; Kim SH; Choi SH
    Clin Microbiol Infect; 2018 Oct; 24(10):1104.e5-1104.e8. PubMed ID: 29870856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Characteristics of Carbapenemase-Producing Enterobacteriaceae in Three Tertiary-Care Korean University Hospitals between 2017 and 2018.
    Kim SH; Kim GR; Jeong J; Kim S; Shin JH
    Jpn J Infect Dis; 2020 Nov; 73(6):431-436. PubMed ID: 32475870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and treatment of IMP-type carbapenemase-producing Enterobacteriaceae bacteremia: Case series and literature review.
    Soneda K; Uda K; Araki K; Murakoshi T; Yuza Y; Saito O; Kinoshita K; Higuchi H; Horikoshi Y
    J Infect Chemother; 2023 Jan; 29(1):26-32. PubMed ID: 36100144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015.
    Albiger B; Glasner C; Struelens MJ; Grundmann H; Monnet DL;
    Euro Surveill; 2015; 20(45):. PubMed ID: 26675038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
    Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
    PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for the development of infections associated with carbapenemase-producing
    Jimenez A; Fennie K; Munoz-Price LS; Ibrahimou B; Abbo LM; Martinez O; Sposato K; Doi Y; Trepka MJ
    Infect Control Hosp Epidemiol; 2021 Jun; 42(6):763-766. PubMed ID: 33213537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Intra-Abdominal Infections Caused by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Oct; 22(8):864-870. PubMed ID: 33857380
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbapenemase producing Enterobacteriaceae in the Netherlands: unnoticed spread to several regions].
    Leenstra T; Bosch T; Vlek AL; Bonten MJM; van der Lubben IM; de Greeff SC
    Ned Tijdschr Geneeskd; 2017; 161():D1585. PubMed ID: 29076442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-Abdominal Infections by Carbapenemase-Producing
    Mora-Guzmán I; Rubio-Perez I; Domingo-Garcia D; Martin-Perez E
    Surg Infect (Larchmt); 2021 Apr; 22(3):266-273. PubMed ID: 32598237
    [No Abstract]   [Full Text] [Related]  

  • 16. Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients.
    Mo Y; Hernandez-Koutoucheva A; Musicha P; Bertrand D; Lye D; Ng OT; Fenlon SN; Chen SL; Ling ML; Tang WY; Barkham T; Nagarajan N; Cooper BS; Marimuthu K
    Emerg Infect Dis; 2020 Sep; 26(9):2182-2185. PubMed ID: 32818397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenemase-producing Enterobacteriaceae isolates resistant to last-line antibiotics in an Italian general hospital.
    Ferranti M; Schiaroli E; Palmieri MI; Repetto A; Vecchiarelli A; Francisci D; Mencacci A; Monari C
    New Microbiol; 2018 Oct; 41(4):274-281. PubMed ID: 30252925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK).
    Woodford N; Xu-McCrae L; Mushtaq S; Wu HHT; Ellington MJ; Lancaster O; Davies F; Donaldson H; Rao GG; Verma A; Wareham DW; Ciesielczuk H; Stone GG; Irani PM; Bracher S; Hawkey PM
    J Antimicrob Chemother; 2018 Mar; 73(3):698-702. PubMed ID: 29253163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing proportion of carbapenemase-producing Enterobacteriaceae and emergence of a MCR-1 producer through a multicentric study among hospital-based and private laboratories in Belgium from September to November 2015.
    Huang TD; Bogaerts P; Berhin C; Hoebeke M; Bauraing C; Glupczynski Y;
    Euro Surveill; 2017 May; 22(19):. PubMed ID: 28537547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.